|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation and amortization of premises and equipment | |||||
| Stock compensation expense | |||||
| Net gain on equity investments | |||||
| Deferred tax (benefit) expense | |||||
| Deferred tax benefit | |||||
| Net amortization (accretion): | |||||
| Securities | |||||
| Loans | |||||
| Right of use asset | |||||
| Software | |||||
| Changes in other assets and liabilities: | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Operating lease liability | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Net change in loans | |||||
| Net change in securities purchased under agreements to resell | |||||
| Purchases of securities available-for-sale | |||||
| Purchases of securities held-to-maturity | |||||
| Principal repayments on securities available-for-sale | |||||
| Principal repayments on securities held-to-maturity | |||||
| Purchases of securities, restricted | |||||
| Proceeds from equity investment | |||||
| Purchase of equity investment | |||||
| Purchases of premises and equipment | |||||
| Development of capitalized software | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase in deposits | |||||
| Decrease in borrowings | |||||
| Exercise of stock options, net of repurchases | |||||
| Tax withholding payments for vested equity awards | |||||
| Cash dividends paid to common stockholders | |||||
| Purchase of common stock | |||||
| Net cash provided by financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the period | |||||
| Cash and cash equivalents at end of the period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Taxes | |||||
| Noncash transactions: | |||||
| Exchange of equity investment for note receivable | |||||
| Dividends declared but not paid | |||||
| Exchange of noncash instruments | |||||
| Right of use asset obtained in exchange for lease liability | |||||
| Cumulative change in accounting principle (Note 1) | |||||
Loading...